Kieran F. Reid

Skeletal muscle power: a critical determinant of physical functioning in older adults.

Muscle power declines earlier and more precipitously with advancing age compared with muscle strength. Peak muscle power also has emerged as an important predictor of functional limitations in older adults. Our current working hypothesis is focused on examining lower extremity muscle power as a more discriminant variable for understanding the relationships between impairments, functional limitations, and resultant disability with aging.

Muscle fiber size and function in elderly humans: a longitudinal study

Cross-sectional studies are likely to underestimate age-related changes in skeletal muscle strength and mass. The purpose of this longitudinal study was to assess whole muscle and single muscle fiber alterations in the same cohort of 12 older (mean age: start of study 71.1+/-5.4 yr and end of study 80+/-5.3 yr) volunteers (5 men) evaluated 8.9 yr apart. No significant changes were noted at follow-up in body weight, body mass index, and physical activity. Muscle strength, evaluated using isokinetic dynamometry, and whole muscle specific force of the knee extensors were significantly lower at follow-up. This was accompanied by a significant reduction (5.7%) in cross-sectional area of the total anterior muscle compartment of the thigh as evaluated by computed tomography. Muscle histochemistry showed no significant changes in fiber type distribution or fiber area. Experiments with chemically skinned single muscle fibers (n=411) demonstrated no change in type I fiber size but an increase in IIA fiber diameter. A trend toward an increase in maximal force in both fiber types was observed. Maximum unloaded shortening velocity did not change. In conclusion, single muscle fiber contractile function may be preserved in older humans in the presence of significant alterations at the whole muscle level. This suggests that surviving fibers compensate to partially correct muscle size deficits in an attempt to maintain optimal force-generating capacity.

Lower Extremity Muscle Mass Predicts Functional Performance in Mobility-Limited Elders

Objectives: This study examined the influence of lower extremity body composition and muscle strength on the severity of mobility-disability in community-dwelling older adults.Methods: Fifty-seven older males and females (age 74.2 ± 7 yrs; BMI 28.9 ± 6 kg/m2) underwent an objective assessment of lower extremity functional performance, the Short Physical Performance Battery test (SPPB). Participants were subsequently classified as having moderate (SPPB score > 7: n = 38) or severe mobility impairments (SPPB score ≤ 7: n = 19). Body composition was assessed using dual-energy X-ray absorptiometry and provided measures of bone mineral density (BMD), total leg lean mass (TLM) and total body fat. Maximal hip extensor muscle strength was estimated using the bilateral leg press exercise. Multiple logistic regression analysis was utilized to identify the significant independent variables that predicted the level of mobility-disability.Results: TLM was a strong independent predictor of the level of functional impairment, after accounting for chronic medical conditions, BMD, body fat, body weight and habitual physical activity. In a separate predictive model, reduced muscle strength was also a significant predictor of severe functional impairment. The severity of mobility-disability was not influenced by gender (p = 0.71). A strong association was elicited between TLM and muscle strength (r = 0.78, p < 0.01).Conclusions: These data suggest that lower extremity muscle mass is an important determinant of physical performance among functionally-limited elders. Such findings may have important implications for the design of suitable strategies to maintain independence in older adults with compromised physical functioning. Additional studies are warranted to assess the efficacy of lifestyle, exercise or therapeutic interventions for increasing lean body mass in this population.

Quality of Life in Sarcopenia and Frailty

The reduced muscle mass and impaired muscle performance that define sarcopenia in older individuals are associated with increased risk of physical limitation and a variety of chronic diseases. They may also contribute to clinical frailty. A gradual erosion of quality of life (QoL) has been evidenced in these individuals, although much of this research has been done using generic QoL instruments, particularly the SF-36, which may not be ideal in older populations with significant comorbidities. This review and report of an expert meeting presents the current definitions of these geriatric syndromes (sarcopenia and frailty). It then briefly summarizes QoL concepts and specificities in older populations and examines the relevant domains of QoL and what is known concerning QoL decline with these conditions. It calls for a clearer definition of the construct of disability, argues that a disease-specific QoL instrument for sarcopenia/frailty would be an asset for future research, and discusses whether there are available and validated components that could be used to this end and whether the psychometric properties of these instruments are sufficiently tested. It calls also for an approach using utility weighting to provide some cost estimates and suggests that a time trade-off study could be appropriate.

Lower extremity power training in elderly subjects with mobility limitations: a randomized controlled trial

Background and aims: This study investigated whether high-velocity high-power training (POW) improved lower extremity muscle power and quality in functionally-limited elders greater than traditional slow-velocity progressive resistance training (STR). Methods: Fifty-seven community-dwelling older adults aged 74.2±7 (range 65–94 yrs), Short Physical Performance Battery score 7.7±1.4, were randomized to either POW (n=23) (12 females), STR (n=22) (13 females) or a control group of lower extremity stretching (CON) (n=12) (6 females). Training was performed three times per week for 12 weeks and subjects completed three sets of double leg press and knee extension exercises at 70% of the one repetition maximum (1RM). Outcome measures included 1RM strength and peak power (PP). Total leg lean mass was determined using dual-energy X-ray absorptiometry to estimate specific strength and specific PP. Results: During training, power output was consistently higher in POW compared to STR for knee extension (∼2.3-fold) and leg press (∼2.8-fold) exercises (p<0.01). Despite this, PP and specific PP of the knee extensors increased similarly from baseline in POW and STR compared to CON (p<0.01), and no significant time-group interaction occurred for PP of the leg extensors. However, gains in leg press specific PP were significantly greater in POW compared to both STR and CON (p<0.05). Total leg lean mass did not change within any group. Conclusions: A short-term intervention of high-velocity power training and traditional slow-velocity progressive resistance training yielded similar increases of lower extremity power in the mobility-impaired elderly. Neuromuscular adaptations to power training, rather than skeletal muscle hypertrophy, may have facilitated the improvements in muscle quality. Additional studies are warranted to test the efficacy of power training in older individuals with compromised physical functioning.

Effect of a 24-Month Physical Activity Intervention vs Health Education on Cognitive Outcomes in Sedentary Older Adults: The LIFE Randomized Trial

IMPORTANCE Epidemiological evidence suggests that physical activity benefits cognition, but results from randomized trials are limited and mixed. OBJECTIVE To determine whether a 24-month physical activity program results in better cognitive function, lower risk of mild cognitive impairment (MCI) or dementia, or both, compared with a health education program. DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial, the Lifestyle Interventions and Independence for Elders (LIFE) study, enrolled 1635 community-living participants at 8 US centers from February 2010 until December 2011. Participants were sedentary adults aged 70 to 89 years who were at risk for mobility disability but able to walk 400 m. INTERVENTIONS A structured, moderate-intensity physical activity program (n = 818) that included walking, resistance training, and flexibility exercises or a health education program (n = 817) of educational workshops and upper-extremity stretching. MAIN OUTCOMES AND MEASURES Prespecified secondary outcomes of the LIFE study included cognitive function measured by the Digit Symbol Coding (DSC) task subtest of the Wechsler Adult Intelligence Scale (score range: 0-133; higher scores indicate better function) and the revised Hopkins Verbal Learning Test (HVLT-R; 12-item word list recall task) assessed in 1476 participants (90.3%). Tertiary outcomes included global and executive cognitive function and incident MCI or dementia at 24 months. RESULTS At 24 months, DSC task and HVLT-R scores (adjusted for clinic site, sex, and baseline values) were not different between groups. The mean DSC task scores were 46.26 points for the physical activity group vs 46.28 for the health education group (mean difference, -0.01 points [95% CI, -0.80 to 0.77 points], P = .97). The mean HVLT-R delayed recall scores were 7.22 for the physical activity group vs 7.25 for the health education group (mean difference, -0.03 words [95% CI, -0.29 to 0.24 words], P = .84). No differences for any other cognitive or composite measures were observed. Participants in the physical activity group who were 80 years or older (n = 307) and those with poorer baseline physical performance (n = 328) had better changes in executive function composite scores compared with the health education group (P = .01 for interaction for both comparisons). Incident MCI or dementia occurred in 98 participants (13.2%) in the physical activity group and 91 participants (12.1%) in the health education group (odds ratio, 1.08 [95% CI, 0.80 to 1.46]). CONCLUSIONS AND RELEVANCE Among sedentary older adults, a 24-month moderate-intensity physical activity program compared with a health education program did not result in improvements in global or domain-specific cognitive function. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT01072500.

Tools in the assessment of sarcopenia.

This review provides a framework for the development of an operational definition of sarcopenia and of the potential end points that might be adopted in clinical trials among older adults. While the clinical relevance of sarcopenia is widely recognized, there is currently no universally accepted definition of the disorder. The development of interventions to alter the natural history of sarcopenia also requires consensus on the most appropriate end points for determining outcomes of clinical importance which might be utilized in intervention studies. We review current approaches to the definition of sarcopenia and the methods used for the assessment of various aspects of physical function in older people. The potential end points of muscle mass, muscle strength, muscle power, and muscle fatigue, as well as the relationships between them, are explored with reference to the availability and practicality of the available methods for measuring these end points in clinical trials. Based on current evidence, none of the four potential outcomes in question is sufficiently comprehensive to recommend as a uniform single outcome in randomized clinical trials. We propose that sarcopenia may be optimally defined (for the purposes of clinical trial inclusion criteria as well as epidemiological studies) using a combination of measures of muscle mass and physical performance. The choice of outcome measures for clinical trials in sarcopenia is more difficult; co-primary outcomes, tailored to the specific intervention in question, may be the best way forward in this difficult but clinically important area.

Habitual Physical Activity Levels are Associated with Performance in Measures of Physical Function and Mobility in Older Men

OBJECTIVES: To determine whether objectively measured physical activity levels are associated with physical function and mobility in older men.

Impaired Voluntary Neuromuscular Activation Limits Muscle Power in Mobility-Limited Older Adults

BACKGROUND Age-related alterations of neuromuscular activation may contribute to deficits in muscle power and mobility function. This study assesses whether impaired activation of the agonist quadriceps and antagonist hamstrings, including amplitude- and velocity-dependent characteristics of activation, may explain differences in leg extension torque and power between healthy middle-aged, healthy older, and mobility-limited older adults. METHODS Torque, power, and electromyography were recorded during maximal voluntary leg extension trials across a range of velocities on an isokinetic dynamometer. RESULTS Neuromuscular activation was similar between middle-aged and older healthy groups, with differences in torque and power explained predominantly by muscle size. However, the older mobility-limited group demonstrated marked impairment of torque, power, and agonist muscle activation, with the greatest deficits occurring at the fastest movement velocities. Agonist muscle activation was found to be strongly associated with torque output. CONCLUSIONS Similar neuromuscular activation between the middle-aged and older healthy groups indicates that impaired voluntary activation is not an obligatory consequence of aging. However, the finding that the mobility-limited group exhibited impaired activation of the agonist quadriceps and concomitant deficits in torque and power output suggests that neuromuscular activation deficits may contribute to compromised mobility function in older adults.

Muscle Performance and Physical Function Are Associated With Voluntary Rate of Neuromuscular Activation in Older Adults

BACKGROUND Muscle power is related to mobility function in older adults, and effective power production requires rapid neuromuscular activation. Accordingly, this study examines the association of neuromuscular activation rate with muscle performance in persons of different age and mobility function. METHODS Participants were recruited to three experimental groups: middle-aged healthy adults (MH), older healthy adults (OH), and older adults with mobility limitations (OML). OH and OML were primarily differentiated by performance on the Short Physical Performance Battery (SPPB). Muscle performance (acceleration and power) and electromyography (EMG) were recorded during a maximal-effort leg press task at an absolute resistance (260 N) and at a relative resistance (70% of the one-repetition maximum [1 RM]). Neuromuscular activation rate was quantified as pre-movement time (duration between EMG onset and movement onset) and the rate of EMG rise. RESULTS Pre-movement time, rate of EMG rise, leg press acceleration, and leg press power were lower in OML relative to MH and OH but did not differ between OH and MH, with the exception of power at 70% 1RM. Across all older participants, rate of EMG rise was positively associated with acceleration, power, and the SPPB score. CONCLUSIONS Slowing of neuromuscular activation rate is associated with compromised dynamic muscle performance, which may contribute to mobility limitations in some older adults. Future research should identify the precise neurophysiological impairments that contribute to declines in neuromuscular activation rate and mobility function with aging.